The 3 most recent market catalysts affecting $VYNE, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Jul 24, 2026
Corporate Catalyst
Bearish
Impact 85
VYNE Therapeutics shares are trading lower after the company announced a 1-for-50 reverse stock split.
A reverse stock split, especially one as aggressive as 1-for-50, is generally viewed as a desperate measure to boost share price and avoid delisting. While it increases the per-sha…
Jul 23, 2026
Corporate Catalyst
Neutral
Impact 65
VYNE Therapeutics Announces 1-For-50 Reverse Stock Split, Effective July 24
VYNE Therapeutics is implementing a 1-for-50 reverse stock split, a corporate action often used by companies whose stock price has fallen significantly, potentially below exchange …
Jul 21, 2026
Corporate Catalyst
Neutral
Impact 75
Vyne Therapeutics Announces 1-For-50 Reverse Stock Split, Special Dividend Of $0.40242/Share Payable To Shareholders Of Record As Of July 22
The 1-for-50 reverse stock split for Vyne Therapeutics (VYNE) is a significant corporate action, primarily aimed at increasing the per-share price to meet exchange listing requirem…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.